ZELTIQ Aesthetics, a medical technology company that develops products using a controlled-cooling technology platform, filed on Wednesday with the SEC to raise up to $115 million in an initial public offering. In September 2010, the FDA approved ZELTIQ's first commercial product, the CoolSculpting System, which aims to reduce fat bulges resistant to diet and exercise. The Pleasanton, CA-based company, which was founded in 2005 and booked $38 million in sales for the 12 months ended March 31, 2011, plans to list on the NASDAQ under the symbol ZLTQ. J.P. Morgan and Goldman, Sachs & Co. are the lead underwriters on the deal. No pricing terms were disclosed.
